Cheng Zeng

9PUBLICATIONS

25CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysisMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 29, 2026

Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer.

|Apr 13, 2026

The Burden of Breast Cancer and its Attributable Risk Factors in 204 Countries and Territories, 1990-2021: Results From the Global Burden of Disease Study 2021.

Jiahui Huang, Jiajin Li, Shengbin Pei

|Dec 24, 2025

The Role of DNA Methyltransferases in Urinary System Diseases.

Wei Dong, Shengbin Pei, Dacheng Zhu

|Sep 25, 2025

Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis.

Cheng Zeng, Shuning Liu, Yuhan Wei

|Aug 16, 2025

A multicenter randomized controlled trial of intrapleural perfusion of methotrexate-loaded tumor cell-derived microparticles combined with systemic therapy for malignant pleural effusion.

Cheng Zeng, Yujing Tan, Zhimin Jiao

|Apr 09, 2025

Investigating cardiovascular diseases related to endocrine therapy in hormone receptor-positive early breast cancer: insights from a nationwide real-world study.

Cheng Zeng, Hong Li, Wenna Wang

Pageof 2

Frequent Collaborators

Fei Ma

Yujing Tan

Shengbin Pei

Huayi Yu

Xiuling Liu

Qian Liu

Jianhua Jin

Fei Ma

Shuning Liu

Yuhan Wei

Frequent Collaborators

Fei Ma

Yujing Tan

Shengbin Pei

Huayi Yu